41-1
41st Parliament,
1st Session
(June 2, 2011 - September 13, 2013)
Select a different session
Meeting Detail
Study on prescription pharmaceuticals in Canada
Topic:
Witnesses
- Andrew Casey, President and Chief Executive Officer (BIOTECanada)
- Jared Rhines, Scientific and Regulatory Affairs (Rx&D)
- Walter Robinson, Vice President, Government Relations (Rx&D)
- David Windross, Vice-President of External Relations, Teva Canada (Canadian Generic Pharmaceutical Association)
Meeting with interpretation and transcription